Everpar Advisors LLC Invests $863,000 in The Cigna Group (NYSE:CI)

Everpar Advisors LLC acquired a new position in The Cigna Group (NYSE:CI) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 2,883 shares of the health services provider’s stock, valued at approximately $863,000.

Several other institutional investors have also recently made changes to their positions in the stock. Bogart Wealth LLC raised its stake in The Cigna Group by 104.5% during the 3rd quarter. Bogart Wealth LLC now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 46 shares during the period. OFI Invest Asset Management bought a new stake in The Cigna Group in the 3rd quarter worth approximately $26,000. Fortitude Family Office LLC bought a new stake in The Cigna Group in the 4th quarter worth approximately $29,000. VisionPoint Advisory Group LLC increased its stake in The Cigna Group by 112.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 104 shares of the health services provider’s stock worth $30,000 after acquiring an additional 55 shares during the last quarter. Finally, Pacifica Partners Inc. boosted its holdings in shares of The Cigna Group by 73.2% in the 4th quarter. Pacifica Partners Inc. now owns 142 shares of the health services provider’s stock worth $43,000 after purchasing an additional 60 shares during the period. Institutional investors own 86.99% of the company’s stock.

Insider Activity at The Cigna Group

In related news, CEO David Cordani sold 38,065 shares of the company’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $335.22, for a total transaction of $12,760,149.30. Following the transaction, the chief executive officer now directly owns 329,321 shares of the company’s stock, valued at approximately $110,394,985.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, CEO David Cordani sold 38,065 shares of the company’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $335.22, for a total transaction of $12,760,149.30. Following the transaction, the chief executive officer now directly owns 329,321 shares of the company’s stock, valued at approximately $110,394,985.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Eric P. Palmer sold 1,017 shares of the company’s stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $335.26, for a total value of $340,959.42. Following the transaction, the insider now directly owns 45,564 shares in the company, valued at $15,275,786.64. The disclosure for this sale can be found here. Insiders have sold 109,277 shares of company stock valued at $37,687,884 in the last ninety days. Corporate insiders own 0.70% of the company’s stock.

The Cigna Group Stock Up 0.2 %

Shares of CI traded up $0.61 during trading hours on Wednesday, hitting $347.31. The company had a trading volume of 1,355,013 shares, compared to its average volume of 1,587,449. The company has a market capitalization of $98.66 billion, a PE ratio of 28.51, a price-to-earnings-growth ratio of 1.04 and a beta of 0.57. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.75. The Cigna Group has a one year low of $240.50 and a one year high of $365.71. The company’s fifty day moving average price is $350.89 and its two-hundred day moving average price is $320.21.

The Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, May 2nd. The health services provider reported $6.47 EPS for the quarter, topping the consensus estimate of $6.17 by $0.30. The firm had revenue of $57.25 billion during the quarter, compared to analyst estimates of $56.59 billion. The Cigna Group had a return on equity of 17.24% and a net margin of 1.76%. The business’s revenue for the quarter was up 23.2% compared to the same quarter last year. During the same period in the previous year, the company posted $5.41 EPS. As a group, equities analysts forecast that The Cigna Group will post 28.45 earnings per share for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 20th. Stockholders of record on Tuesday, June 4th will be given a $1.40 dividend. This represents a $5.60 annualized dividend and a dividend yield of 1.61%. The ex-dividend date is Tuesday, June 4th. The Cigna Group’s payout ratio is 45.98%.

Analysts Set New Price Targets

CI has been the subject of a number of recent research reports. Barclays initiated coverage on The Cigna Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $393.00 target price for the company. StockNews.com upgraded The Cigna Group from a “buy” rating to a “strong-buy” rating in a report on Thursday, March 14th. Wells Fargo & Company boosted their price objective on The Cigna Group from $334.00 to $348.00 and gave the company an “equal weight” rating in a report on Tuesday, February 6th. Morgan Stanley restated an “overweight” rating and set a $392.00 price objective (up previously from $382.00) on shares of The Cigna Group in a report on Monday, March 4th. Finally, Royal Bank of Canada upgraded The Cigna Group from a “sector perform” rating to an “outperform” rating and boosted their price objective for the company from $327.00 to $354.00 in a report on Monday, February 5th. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and an average target price of $366.14.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.